Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer
作者： Rita Nahta , Dihua Yu , Mien-Chie Hung , Gabriel N Hortobagyi , Francisco J Esteva
DOI: 10.1038/NCPONC0509
关键词:
摘要: Trastuzumab is a monoclonal antibody targeted against the human epidermal growth factor receptor (HER) 2 tyrosine kinase receptor, which is overexpressed in approximately 25% of …
nature.com
sci-hub.se 参考文章(103)
Kermit L. Carraway, Shari A. Price-Schiavi, Masanobu Komatsu, Scott Jepson, Aymee Perez, Coralie A. Carothers Carraway, Muc4/Sialomucin Complex in the Mammary Gland and Breast Cancer Journal of Mammary Gland Biology and Neoplasia. ,vol. 6, pp. 323- 337 ,(2001) , 10.1023/A:1011327708973
M D Pegram, R J Pietras, S B Howell, V R Chazin, B M Fendly, D J Slamon, Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells. Oncogene. ,vol. 9, pp. 1829- 1838 ,(1994)
Richard J. Pietras, David Gallardo, P. Nancy Wongvipat, H. Julie Lee, Joseph C. Poen, Dennis J. Slamon, Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene. Cancer Research. ,vol. 59, pp. 1347- 1355 ,(1999)
Suzanne A. Eccles, The Role of c-erbB-2/HER2/neu in Breast Cancer Progression and Metastasis Journal of Mammary Gland Biology and Neoplasia. ,vol. 6, pp. 393- 406 ,(2001) , 10.1023/A:1014730829872
Ina-Maria Harwerth, Nancy E. Hynes, Bernd Groner, Marcel Mueller, Winfried Wels, Selective Inhibition of Tumor Cell Growth by a Recombinant Single-Chain Antibody-Toxin Specific for the erbB-2 Receptor Cancer Research. ,vol. 52, pp. 6310- 6317 ,(1992)
Francisco J Esteva, Carol D Cheli, Herbert Fritsche, Monica Fornier, Dennis Slamon, Robert P Thiel, Diana Luftner, Farooq Ghani, Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies Breast Cancer Research. ,vol. 7, pp. 1- 8 ,(2005) , 10.1186/BCR1020
Steven Seelig, Carlos L. Arteaga, Walter King, F. Michael Yakes, Wichai Chinratanalab, Christoph A. Ritter, Herceptin-induced Inhibition of Phosphatidylinositol-3 Kinase and Akt Is Required for Antibody-mediated Effects on p27, Cyclin D1, and Antitumor Action Cancer Research. ,vol. 62, pp. 4132- 4141 ,(2002)
S Paik, R Hazan, E R Fisher, R E Sass, B Fisher, C Redmond, J Schlessinger, M E Lippman, C R King, Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. Journal of Clinical Oncology. ,vol. 8, pp. 103- 112 ,(1990) , 10.1200/JCO.1990.8.1.103
Michael F. Press, Dennis J. Slamon, Kerry J. Flom, Jinha Park, Jian-Yuan Zhou, Leslie Bernstein, Evaluation of HER-2/neu Gene Amplification and Overexpression: Comparison of Frequently Used Assay Methods in a Molecularly Characterized Cohort of Breast Cancer Specimens Journal of Clinical Oncology. ,vol. 20, pp. 3095- 3105 ,(2002) , 10.1200/JCO.2002.09.094
M F Press, L Bernstein, P A Thomas, L F Meisner, J Y Zhou, Y Ma, G Hung, R A Robinson, C Harris, A El-Naggar, D J Slamon, R N Phillips, J S Ross, S R Wolman, K J Flom, HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. Journal of Clinical Oncology. ,vol. 15, pp. 2894- 2904 ,(1997) , 10.1200/JCO.1997.15.8.2894